Additive therapy in the maintenance of remission in acute lymphoblastic leukemia of childhood: the effect of the initial leukocyte count.
D000293:Adolescent; D000367:Age Factors; D001769:Blood / Q000187:drug effects; D001932:Brain Neoplasms / Q000150:complications; D002648:Child; D002675:Child, Preschool; D003609:Dactinomycin / Q000627:therapeutic use*; D004064:Digestive System / Q000187:drug effects; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D007958:Leukocyte Count; D008466:Mechlorethamine / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D013997:Time Factors
D003609:Dactinomycin; D008466:Mechlorethamine; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate